Modern implantable biomaterial for dental and maxillofacial procedures. Available in 1cm, 3cm, and 5cm sizes.
Third-generation biphasic (hydroxyapatite-polymeric) biomaterial, bioactive, supporting bone tissue regeneration. After implantation, it integrates with the patient's bone and is slowly remodelled into natural bone tissue — eliminating the need for reoperation.

Product overview showcasing the dental bone filler properties, flexibility, and clinical applications.
Clinical demonstration of FlexiOss® in dental procedures including socket preservation and bone augmentation.
Plastic and bendable — fits individual bone defects by cutting or bending
Compatible with natural bone tissue for seamless integration
Similar to those of cancellous bone — structural support
Actively supports the bone reconstruction process
High soaking capacity for enhanced drug delivery
Positively affects bone tissue regeneration process
High ionic reactivity increases mineralization rate
Thoroughly tested for safety — no cytotoxicity
Can be used for bone defects of up to 7 cm in length
Lowers risk of pathogen transmission and allergic reactions
Simple storage and transportation requirements
Allows fitting during operation to the shape of individual bone defects by cutting or bending.
In dry state, FlexiOss® Dent can be milled for personalized composite implants.
High specific surface area and ionic reactivity increases mineralization rate and new bone formation.
Curdlan polymer minimizes virus/prion risk. Forms collagen-like triple helix neutral to macrophages.
Can be soaked in antibacterial drugs, PRP, or growth factors — resembling expensive BMP-2-type substitutes.
No special conditions needed. Simple logistics for clinics worldwide.
Biphasic (hydroxyapatite-polymeric) composite obtained by polymer gelling into an irreversible, collagen-like triple helix — neutral for macrophages, no local inflammation.
EC Certificate No. 1434-MDD-269/2021
European conformity — highest safety standards
CMDR-2025-04943B
Certified for dental & maxillofacial applications
European Patents
England, Austria, France, Spain, Ireland, Germany, Poland, Italy
Cat oronasal fistula filling procedure with X-ray evaluation directly after implantation and 1 month post-op showing positive integration.
Dog oronasal fistula filling — removal of luxated canine tooth and filling of the fistula with FlexiOss® Dent biomaterial.
MicroCT (pQCT) evaluation showing bone density increase from implantation through 1, 3, and 6 months — confirming progressive bone formation.
Histological images confirming bone cells, laminae, collagen fibres and Haversian canals at implantation site — unequivocal bone tissue formation.
Treatment of gingival resection with serious atrophy of interdental gingiva and bone tissue between 21st and 22nd teeth — successful regeneration.
Successful filling of dental defect after cystotomy procedure — demonstrating remodelling and formation of bone tissue with no side effects.
Clinical observations conducted at New-Dent Stomatological Center, Lublin, Poland and Animal Surgery Clinic, University of Life Sciences, Lublin
Krasny K., Wróblewski S., Wojtowicz A., Kamiński A.
Borkowski L., Lubek T., Jojczuk M., Nogalski A., Belcarz A., Palka K., Hajnos M., Ginalska G.
Borkowski L., Kiernicka M., Belcarz A., Palka K., Hajnos M., Ginalska G.
Borkowski L., Sroka-Bartnicka A., et al.
Belcarz A., Zima A., Ginalska G.
Belcarz A., Ginalska G., Pycka T., et al.
Krasny K., Wroblewski S., Wojtowicz A., Kaminski A.